The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes
Clinical trial NCT05078255 · COMPLETED
Trial details
- NCT number
- NCT05078255
- Sponsor
- Asger Lund, MD
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2025-01-06
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.